Massive angola trial pits moxidectin against ivermectin to end river blindness
NCT ID NCT07145736
First seen Nov 21, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study compares two FDA-approved drugs, moxidectin and ivermectin, to see which is better at reducing river blindness and other parasitic infections when given yearly to entire communities in Angola. Over 52,000 people will take part, and researchers will track infection rates, parasite levels, and transmission by blackflies. The goal is to find the most effective strategy for eliminating these diseases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOOKWORM INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Villages in Andulo and Nharea Municipalities
RECRUITINGAndulo, Bíe Province, Angola
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.